|
Xi`an Changyue Biological Technology Co., Ltd,
|
Purple powder, has good prevention effect to disease (1) high levels of antioxidants, 33 times that of red wine, can lower blood pressure and prevent thrombosis;
2. High levels of beneficial fatty acids, can balance the human body blood fat and reduce the incidence of hyperlipidemia, diabetes and heart disease;
3. A large amount of edible cellulose;
4. Rich in amino acids;
5. A variety of natural vitamins and minerals. |
Send Inquiry
|
|
SHANXI YONGJIN GROUP CO LTD
|
Product Name：Artemether
Other Name：3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (5aS,6R,8aS,9R,10S,12R,12aR)-丨Gvither丨(4S,5R,8S,9R,10S,12R,13R)-10-Methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0.0]hexadecane
Molecular Formula：C16H26O5
Molecular Weight：298.375
Use：Artemether is an antimalarial for the treatment of resistant strains of falciparum malaria.Target: AntiparasiticArtemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. Artemether exhibits the highest activity against juvenile stages of the parasites, while adult worms are significantly less susceptible. There was no indication of neurotoxicity following repeated high doses of artemether given fortnightly for up to 5 months. Artemether-integrated with other control strategies-has considerable potential for reducing the current burden of schistosomiasis in different epidemiological settings [1]. There were remarkably inhibitory effects of artmeter on brain glioma growth and angiogenesis in SD rats and the mechanism that artemether inhibited brain glioma growth might be penetrating the blood-brain barrier and inhibiting angiogenesis [2].
|
Send Inquiry
|
|
Tianjin Sinomed Pharmaceutical Co., Ltd.
|
Product Name:Artemether Injection
Specification: 80mg/1ml,40mg/1ml
Packing:6's/tray/box & 8's/tray/box
Registration documents are available.
If you are interested in our products, please feel free to contact us. |
Send Inquiry
|
Pharma Sources Insight January 2025
